Skip to content
Cancer — AntimetabolitesATC L01BC05

Gemcitabine

Prescription onlyWHO essential medicine

Nucleoside chemotherapy for pancreatic, lung, bladder and ovarian cancers.

Starts working
Depends on the cancer and regimen
Half-life
Minutes (gemcitabine); 8–17 hours (metabolite)
In use since
—
Pregnancy
Usually avoided

Overview

Gemcitabine is used alone or with platinum or taxane drugs. It lowers blood counts and may cause flu-like symptoms and rash after infusion.

How it works

Blocks cancer cells from copying their DNA.

Gemcitabine belongs to the Antimetabolites. How Antimetabolites work: look like the raw materials of DNA, so dividing cells make faulty copies or stall.

Uses

  • Pancreatic cancer
  • Lung cancer
  • Ovarian cancer
  • Bladder and breast cancer

Available as: iv infusion.

Typical dose

Adults
Dosed by your cancer team according to the treatment protocol.
Good to know
Doses depend on body size, blood counts and the regimen.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Low blood counts
  • Nausea
  • Rash
  • Flu-like symptoms
  • Swollen ankles

Serious — get medical help

Uncommon, but need prompt attention

  • Severe low blood counts
  • Lung inflammation
  • Haemolytic uraemic syndrome (rare)
  • Capillary leak (rare)

Warnings

  • Report breathlessness promptly

Who should avoid it

  • Severe kidney or liver impairment
  • Radiotherapy given at the same time
  • Pregnancy

Interactions

  • Radiotherapy — severe toxicity if given together
  • Live vaccines — avoid

Other medicines in the atlas that need care with Gemcitabine, grouped by the reason:

Added bone marrow suppressionModerateWith Azathioprine, Bortezomib, Capecitabine, Carbimazole, Carboplatin and 26 more
Bleeding risk with low plateletsModerateWith Aspirin, Cilostazol, Clopidogrel, Dipyridamole, Prasugrel and 1 more

Antiplatelet treatment adds to bleeding risk when another medicine suppresses platelet production.

What's usually done: Monitor blood counts and report unusual bruising or bleeding.

Check Gemcitabine against your own medicines

Using it safely

Alcohol
Best to limit. Alcohol can add to nausea and tiredness; ask your cancer team.
Food and drink
Follow your cancer team's advice.
If you miss a dose
Contact your cancer team; do not double up.
Stopping it
Only your cancer team should change or stop treatment.
Driving
Tiredness or dizziness may affect driving.
Tests and checks
Blood counts; Liver and kidney tests; Breathing
If too much is taken
Overdose can cause severe low blood counts or organ damage. Seek emergency help.
Storage
Refrigerate unless the label says otherwise.
Legal status
United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HAustralia: Prescription only (Schedule 4)

Pregnancy and breastfeeding

Pregnancy

Usually avoided

Can harm a developing baby. Effective contraception is advised during and after treatment.

Breastfeeding

Usually avoided

Avoid breastfeeding during treatment.

Special groups

Kidney disease
Dose may need adjusting; your team will advise.
Liver disease
Dose may need adjusting; your team will advise.
Older adults
Older adults may be more sensitive to side effects.

Brand names

United States
Gemzar, Infugem
United Kingdom
Gemzar
India
Gemcite, Gemzar
Australia
Gemzar

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

Common questions

Do I need a prescription for Gemcitabine?

Yes — Gemcitabine is prescription-only in most countries.

Can I take Gemcitabine during pregnancy?

Usually avoided. Can harm a developing baby. Effective contraception is advised during and after treatment. Always check with a doctor or midwife.

How quickly does Gemcitabine work?

Depends on the cancer and regimen.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.